Thromboembolic phenomena in inflammatory bowel disease and risk with JAK inhibitor treatments

被引：0
|
作者：
Garcia, Jose Luis Rueda [1 ,2 ]
Benitez, Jose Manuel [3 ]
Rey, Iria Baston [4 ]
Sard, Margalida Calafat [5 ]
Ferrer, Cristina Suarez [1 ,2 ]
机构：
[1] Hosp Univ La Paz, Serv Gastroenterol, Unidad EII, Madrid, Spain
[2] Univ La Paz IdiPAZ, Grp Invest Enfermedades Gastrointestinales Inmunom, Inst Invest Hosp, Madrid, Spain
[3] Hosp Univ Reina Sofia, Unidad EII, IMIBIC, Serv Gastroenterol, Cordoba, Spain
[4] Complejo Hosp Univ Santiago De Compostela, Serv Gastroenterol, Unidad EII, Santiago De Compostela, Spain
[5] Hosp Badalona Germans Trias & Pujol, Serv Gastroenterol, Unidad EII, Badalona, Spain
来源：
GASTROENTEROLOGIA Y HEPATOLOGIA | 2025年 / 48卷 / 01期
关键词：
VENOUS THROMBOEMBOLISM; THERAPY; EVENTS; UPADACITINIB; METAANALYSIS; MORTALITY;
D O I：
10.1016/j.gastrohep.2024.502257
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Thromboembolic Events in Hospitalized Patients with Inflammatory Bowel Disease
    Alfred D. Nelson
    Daniela Fluxá
    Freddy Caldera
    Francis A. Farraye
    Jana G. Hashash
    Paul T. Kröner
    Digestive Diseases and Sciences, 2023, 68 : 2597 - 2603
  • [42] Thromboembolic Events in Hospitalized Patients with Inflammatory Bowel Disease
    Nelson, Alfred D.
    Fluxa, Daniela
    Caldera, Freddy
    Farraye, Francis A.
    Hashash, Jana G.
    Kroner, Paul T.
    DIGESTIVE DISEASES AND SCIENCES, 2023, 68 (06) : 2597 - 2603
  • [43] Clinical presentation of thromboembolic events in inflammatory bowel disease
    Bollen, L.
    Vande Casteele, N.
    Ballet, V
    Vermeire, S.
    Gils, A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 612 - 612
  • [44] Ileocolonic-Targeted JAK Inhibitor: A Safer and More Effective Treatment for Inflammatory Bowel Disease
    Yadav, Vipul
    House, Aileen
    Matiz, Silvia
    McCoubrey, Laura E.
    Bettano, Kimberly A.
    Bhave, Leena
    Wang, Meiyao
    Fan, Peter
    Zhou, Siqun
    Woodhouse, Janice D.
    Poimenidou, Eirini
    Dou, Liu
    Basit, Abdul W.
    Moy, Lily Y.
    Saklatvala, Robert
    Hegde, Laxminarayan G.
    Yu, Hongshi
    PHARMACEUTICS, 2022, 14 (11)
  • [45] Proton pump inhibitor use and the risk of flare of inflammatory bowel disease
    Aberra, Faten
    Lewis, James D.
    Lichtenstein, Gary R.
    Yang, Yu-Xiao
    GASTROENTEROLOGY, 2006, 130 (04) : A649 - A649
  • [46] JAK1 inhibition and inflammatory bowel disease
    Harris, Clare
    Cummings, J. R. Fraser
    RHEUMATOLOGY, 2021, 60 (SUPPL 2) : ii45 - ii51
  • [47] Efficacy of JAK Inhibitors in Patients With Inflammatory Bowel Disease
    Qirem, Murad
    Pulakurthi, Yashwitha Sai
    Aiman, Wajeeha
    Ahmad, Amaar
    Battah, Arwa
    Shamoon, Dema
    Bains, Yatinder
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S646 - S647
  • [48] Acne due to JAK inhibitors in inflammatory bowel disease
    Awad, Andrew
    Christensen, Britt
    Segal, Jonathan P.
    Ross, Gayle
    FRONTLINE GASTROENTEROLOGY, 2024,
  • [49] JAK Inhibition as a Therapeutic Strategy for Inflammatory Bowel Disease
    Macaluso, Fabio Salvatore
    Rodriguez-Lago, Iago
    CURRENT DRUG METABOLISM, 2020, 21 (04) : 247 - 255
  • [50] JAK inhibitors for inflammatory bowel disease: recent advances
    Honap, Sailish
    Agorogianni, Alexandra
    Colwill, Michael J.
    Mehta, Sonia Kalyanji
    Donovan, Fiona
    Pollok, Richard
    Poullis, Andrew
    Patel, Kamal
    FRONTLINE GASTROENTEROLOGY, 2024, 15 (01) : 59 - 69
12345